Poly I:C immunotherapy in patients with papillomas or superficial carcinomas of the bladder.
A randomized prospective therapeutic trial of poly I:C immunotherapy in patients with papillomas or superficial carcinomas of the bladder is presented. Poly I:C had no beneficial effect on the recurrence rate of superficial bladder tumors.
D002294:Carcinoma, Squamous Cell / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D006801:Humans; D010212:Papilloma / Q000188:drug therapy*; D011070:Poly I-C / Q000627:therapeutic use*; D012008:Recurrence; D001749:Urinary Bladder Neoplasms / Q000188:drug therapy*
D011070:Poly I-C